Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Utilizing Clinicopathological and Radiomic Features for Risk Stratification of Lung Cancer Recurrence

Academic Radiology(2025)10.1016/j.acra.2025.04.062Source: DataRank Database

Utilizing Clinicopathological and Radiomic Features for Risk Stratification of Lung Cancer Recurrence is a research paper published in Academic Radiology (2025). On theSindex it has a DataRank of 0. It has been cited 6 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

6 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 3.97)OA: closedTopics (42)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Nikolai Fetisov,Lawrence Hall ORCID,Dmitry B. Goldgof ORCID,Matthew B. Schabath ORCID,Wai Lone Jonathan Ho ORCID

Live enrichment

PubMed:40379589 PMC:PMC12667037 OpenAlex:https://openalex.org/W4410407093

National Cancer Institute Division of Cancer Prevention

Grant: U01-CA200464

National Cancer Institute Division of Cancer Prevention

Grant: P30-CA76292

NCI NIH HHS

Grant: U01 CA200464

NCI NIH HHS

Grant: U01 CA143062

NCI NIH HHS

Grant: P30 CA076292

National Institutes of Health

National Cancer Institute

FWCI

3.97

Citation Percentile

0.9%

Citation Trend

2026

closedLicense: https://www.elsevier.com/legal/tdmrep-license

publisherhttps://api.elsevier.com/content/article/PII:S1076633225004155?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1076633225004155?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.acra.2025.04.062

repositoryhttps://pubmed.ncbi.nlm.nih.gov/40379589

Fields of Study

Radiomics and Machine Learning in Medical ImagingLung Cancer Diagnosis and TreatmentCancer Immunotherapy and BiomarkersHumansLung NeoplasmsMaleFemaleNeoplasm Recurrence, LocalCarcinoma, Non-Small-Cell LungMiddle AgedRisk AssessmentAgedTomography, X-Ray ComputedNeoplasm StagingRetrospective StudiesRadiomics

MeSH Terms

RadiomicsAgedCarcinoma, Non-Small-Cell LungFemaleHumansLung NeoplasmsMaleMiddle AgedNeoplasm Recurrence, LocalNeoplasm StagingRetrospective StudiesTomography, X-Ray ComputedRisk Assessment

Keywords

Risk stratificationLung cancerMedicineRadiomicsStratification (seeds)RadiologyOncologyInternal medicineBiologyRecurrenceNSCLCcomputed tomographyPyradiomics

Sustainable Development Goals

SDG 0: Good health and well-being

Utilizing Clinicopathological and Radiomic Features for Risk Stratification of Lung Cancer Recurrence

FAIR Checklist

Authors (5)

Funding (7 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)